Literature DB >> 7257764

Cholecystic granulomas in gallstone disease. A clinicopathologic study of 17 cases.

M Hanada, T Tujimura, M Kimura.   

Abstract

This paper concerns with 17 cases of chronic cholecystitis with various granulomatous changes of the wall. All materials were obtained from patients who underwent cholecystectomy for various complications of gallstone disease. The only significant sign attributable to the granulomas was a palpable nodular induration in the wall at operation in several cases, and this led to a suspicion of neoplasm in one. Pathologically, these lesions were characterized principally by nodular proliferation (0.5-3.0 cm in size) of various forms of histiocytic cells, including lipid-containing histiocytes (foam cells), PAS positive brown pigmented cells, and multinucleated giant cells. Deposition of bile pigment and/or cholesterin crystals were found deeply in the areas of granulomatous reaction in about two-thirds of the cases. This finding supports a bile-induced granulomatous process of these lesions. The granuloma in one of our series contained typical Michaelis-Gutmann bodies seen in a case of malakoplakia. It is suggested that bile materials, which are capable of eliciting intense phagocytic reaction, may also act as an initiating factor in formation of malakoplakic lesions.

Entities:  

Mesh:

Year:  1981        PMID: 7257764

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  3 in total

1.  Gallbladder malakoplakia in type 2 diabetes mellitus: a rare entity.

Authors:  Kim Vaiphei; Priya Singh; Ganga Ram Verma
Journal:  BMJ Case Rep       Date:  2012-08-27

2.  Xanthogranulomatous gastritis: association with xanthogranulomatous cholecystitis.

Authors:  M Guarino; D Reale; G Micoli; P Tricomi; E Cristofori
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

3.  Xanthogranulomatous gastritis: an entity or a secondary phenomenon?

Authors:  M A Parsons
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.